Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Only the adverse events affecting skin, subcutaneous tissue and skin appendages (also known as ‘skin toxicity’ or ‘skin changes’) secondary to EGFRI treatment are addressed here. This section, ‘Symptoms and grading’, comprises the following sub-sections:

  • Terminology: the vocabulary used on the website for the description and grading of EGFRI-related skin toxicities.
  • Incidence: the frequency of EGFRI-related skin toxicities.
  • Skin changes: the EGFRI-associated cutaneous changes, given by type and grade.
  • Nail changes: the EGFRI-associated nail changes, given by type and grade.
  • Hair changes: the EGFRI-associated hair changes, given by type and grade.
  • Mucosal changes: the EGFRI-associated changes of Mucous membranes, given by type and grade.
  • Differential diagnosis: common skin changes unrelated to EGFRI treatment.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings